Cytokine release and innate immunity in respiratory viral infection

Seminars in Virology

Volumn 7, Issue 4, 1996, Pages 255-264

  Neuzil, Kathleen Maletic ^a   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Immunity; Influenza; Respiratory syncytial virus

Indexed keywords

CYTOKINE; INTERFERON;

ARTICLE; CELL TYPE; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE; VIRUS INFECTION;

INFLUENZA VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0030220527     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0032     Document Type: Article

References (72)

1. 1. Falsey AR, Walsh EE (1992) Humoral immunity to respiratory syncytial virus infection in the elderly. J Med Virol 36:39-43
2. 2. Englund JA, Anderson LJ, Rhame FS (1991) Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Micro 29:115-119
3. 3. Hertz MI, Englund JA, Snover D, Bitterman PB, McGlave PB (1989) Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 68:269-281
4. 4. Johnson KM, Bloom HH, Mufson MA, Chanock RM (1962) Natural reinfection of adults by respiratory syncytial virus. N Engl J Med 267:68-72
5. 5. Hall CB, Walsh EE, Long CE, Schnabel KC (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698
6. 6. Welliver RC (1988) Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Micro Rev 1:27-39
7. 7. Graham B, Bunton L, Wright P, Karzon DT (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88:1026-1033
8. 8. Fulginiti V, Eller J, Sieber O, et al (1969) Respiratory virus immunization - a field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435-440
9. 9. Kim H, Canchola J, Brandt C, et al (1969) Respiratory syncytial disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422-434
10. 10. Chin J, Magoffin R, Shearer L, Schieble J, Lennette E (1969) Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89:449-463
11. 11. Kapikian A, Mitchell R, Chanock R, Shevedoff R, Stewart C (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421
12. 12. Mathur U, Bentley DW, Hall CB (1980) Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 93:49-52
13. 13. Murphy BR, Webster RG (1996) Orthomyxoviruses, in Virology (Fields BN, Knipe DM, Howley PM, eds pp 1399-1404. Lippincott-Raven Publishers, Philadelphia
14. 14. Mills J, VanKirk JE, Wright PF, Chanock RM (1971) Experimental respiratory syncytial virus infection of adults. J Immunol 107:123-131
15. 15. Janeway CA, Travers P (1994) Basic Concepts in Immunology, in Immunobiology. The immune system in health and disease, pp 28-34. Current Biology Ltd/Garland Publishing Inc., London
16. 16. Gershwin L, Dungworth D, Himes S, Friebertshauser K (1990) Immunoglobulin E responses and lung pathology resulting from aerosol exposure of calves to respiratory syncytial virus and micropolysporta faeni. Int Arch Allergy Appl Immunol 92:293-300
17. 17. Alwan WH, Openshaw PJ (1993) Distinct patterns of T-and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431-437
18. 18. Tang Y-W, Graham BS (1994) Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 94:1953-1958
19. 19. Levine SJ (1995) Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 43:241-249
20. 20. Elias JA, Zheng T, Elinarsson O, et al (1994) Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 269:22261-22268
21. 21. Becker S, Koren HS, Henke DC (1993) Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Resp Cell Mol Biol 8:20-27
22. 22. Noah TL, Becker S (1993) Respiratory syncytial-virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265:L472-L478
23. 23. Arnold R, Humbert B, Werchau H, Gallati H, Konig W (1994) Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunol 82:126-133
24. 24. Subauste MC, Jacoby DB, Richards SM, Proud D (1995) Infection of a human respiratory epithelial cell line with rhinovirus. J Clin Invest 96:549-557
25. 25. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG (1991) Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 266:19611-19617
26. 26. Uyttenhove C, Coulie PG, Snick JV (1988) T cell growth and differentiation induced by interleukin-HP1/ IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 167:1417-1427
27. 27. Kishimoto T, Akira S, Taga T (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593-597
28. 28. Ramsay AJ, Husband AJ, Ramshaw IA, et al (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563
29. 29. Wong GHW, Goeddel DV (1986) Tumour necrosis factors α and β inhibits virus replications and synergize with interferons. Nature 323:819-822
30. 30. Sambhi SK, Kohonen-Corish MR, Ramshaw IA (1991) Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci USA 88:4025-4029
31. 31. Choi AM, Jacoby DB (1992) Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett 309:327-329
32. 32. Noah TL, Henderson F, Wortman I, et al (1995) Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171:584-592
33. 33. Neuzil KM, Gruber WC, Graham BS (1996) Local and systemic cytokine response in children hospitalized with respiratory syncytial virus infection (in press)
34. 34. Okamoto Y, Kudo K, Ishikawa K, et al (1993) Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis 168:1277-1288
35. 35. Ohtoshi T, Vancheri C, Cox G, et al (1991) Monocyte-macrophage differentiation induced by human upper airway epithelial cells. Am J Resp Cell Mol Biol 4:255-263
36. 36. Liles WC, Voorhis WCV (1995) Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 172:1573-1580
37. 37. Ray C, Gravelle C, Chin T (1967) Circulating Interferon in infants and children with acute respiratory illness. J Pediatr 71:27-32
38. 38. Hall CB, Douglas RG, Simons RL, Geiman JM (1978) Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr 93:28-32
39. 39. McIntosh K (1978) Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr 93:33-36
40. 40. Nakayama T, Sonoda S, Urano T, et al (1993) Detection of alpha-interferon in nasopharyngeal secretions and sera in children infected with respiratory syncytial virus. Ped Infect Dis J 12:925-929
41. 41. Chonmaitree T, Roberts NJ, Gordon Douglas JR, Hall CB, Simons RL (1981) Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses. Infect Immun 32:300-303
42. 42. Roberts NJ, Prill AH, Mann T (1986) Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. J Exp Med 163:511-519
43. 43. Neuzil KM, Tang Y-W, Graham BS (1996) Protective effects of TNF-α on respiratory syncytial virus infection in vitro and in vivo. Am J Med Sci 311:201-204
44. 44. Wong G, Krowka J, Stites D, Goeddel D (1988) Anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J Immunol 140:120-124
45. 45. Tufariello J, Cho S, Horwitz M (1994) The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J Virol 68:453-462
46. 46. Midulla F, Huang YT, Gilbert IA, et al (1989) Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am Rev Resp Dis 140:771-777
47. 47. Cirino NM, Panuska JR, Villani A, et al (1993) Restricted replication of respiratory syncytial virus in human alveolar macrophages. J Gen Virol 74:1527-1537
48. 48. Becker S, Quay J, Soukup J (1991) Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147:4307-4312
49. 49. Hinder F, Schmidt A, Gong JH, et al (1990) Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. Pathobiol 59:227-231
50. 50. Panuska JR, Midulla F, Cirino NM, et al (1990) Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. Am J Physiol 259:L396-L402
51. 51. Midulla F, Villani A, Panuska J, et al (1993) Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis 168:1515-1519
52. 52. Panuska JR, Hertz MI, Taraf H, Villani A, Cirino NM (1992) Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. Am Rev Resp Dis 145:934-939
53. 53. Preston FM, Beier PL, Pope JH (1995) Identification of the respiratory syncytial virus-induced immunosuppressive factor produced by human peripheral blood mononuclear cells as interferon-α. J Infect Dis 172:919-926
54. 54. Becker S, Soukup J, Yankaskas J (1992) Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am J Respir Cell Mol Biol 6:369-374
55. 55. Panuska JR, Merolla R, Rebert NA, et al (1995) Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. J Clin Invest 96:2445-2453
56. 56. Fiorentino D, Zlotnik A, Mosmann TR, Howard M, O'Gann A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
57. 57. Graham B, Henderson G, Tang Y et al (1993) Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 151:2032-2040
58. 58. Moore K, O'Garra A, Malefyt RDW, Vieira P, Mosmann TR (1993) Interleukin-10. Ann Rev Immunol 11:165-190
59. 59. Tang YW, Graham BS (1995) Interleukin-12 treatment during immunization elicits a T helper cell Type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J Infect Dis 172:734-738
60. 60. Gong J-H, Sprenger H, Hinder E, et al (1991) Influenza A virus infection of macrophages. J Immunol 147:3507-3513
61. 61. Pahl HL, Baeuerle PA (1995) Expression of influenza virus hemagglutinin activates transcription factor NK-Ee Cyrillic signβ. J Virol 69:1480-1484
62. 62. Wada N, Matsumura M, Ohba Y, et al (1995) Transcription stimulation of the Fas-encoding gene by Nuclear Factor for interleukin-6 expression upon influenza virus infection. J Biol Chem 270:18007-18012
63. 63. Jamaluddin M, Garofalo R, Ogra PL, Brasier AR (1996) Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol 70:1554-1563
64. 64. Conn CA, McClellan JL, Maassab HF, et al (1995) Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268:R78-R84
65. 65. Hennet T, Ziltener HJ, Frei K, Peterhans E (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149:932-939
66. 66. Vacheron F, Rudent A, Perin S, et al (1990) Production of interleukin 1 and tumour necrosis factor activities in bronnß choalveolar washings following infection of mice by influenza virus. J Gen Virol 71:477-479
67. 67. Baumgarth N, Brown L, Jackson D, Kelso A (1994) Novel features of the respiratory tract T-cell response to infuenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J Virol 68:7575-7581
68. 68. Hayes PJ, Scott R, Wheeler J (1994) In vivo production of tumour necrosis factor-α and interleukin-6 in BALB/ c mice inoculated intranasally with a high dose of respiratory syncytial virus. J Med Virol 42:323-329
69. + lymphocytes reduces immunopathology in RSV-infected mice. (Submitted)
70. 70. Welliver RC, Duffy L (1993) The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 15:19-27
71. 71. Chandwani SW, Borkowsky KK, Lawrence R, Welliver R (1990) Respiratory syncytial virus infection in HIV-infected children. J Pediatr 117:251-254
72. 72. King JC, Burke AR, Clemens JD, et al (1993) Respiratory syncytial viral illnesses in HIV-infected and noninfected chilndren. Ped Infect Dis J 12:733-739